RxDoctor Payments Data

Melanie Monnig

Physician Assistant · Newark, DENPI 1730188301

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 11.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $697 and has fallen 87.9% since, to $84 in 2025.

$2,216in general payments, 2019–2025

Across 130 payments — averaging $17.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$245
  • AstraZeneca$240
  • GSK$239
  • Johnson & Johnson$222
  • Astellas Pharma US Inc$205
  • AbbVie$169
  • plus $895 from 21 others

What the payments were for

  • Food & beverage$2,20499%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,216 in reported general payments places this provider in the 85th percentile of 527 physician assistant providers in Delaware.

See all physician assistant providers in Delaware

Most prescribed under Part D

DrugClaimsCost to plans & patients
Janumet XrSitagliptin Phos/Metformin Hcl16$10,884
Atorvastatin Calcium90$811
Albuterol Sulfate HfaAlbuterol Sulfate16$618
Omeprazole30$574
Rosuvastatin Calcium17$544
Gabapentin16$420
Amlodipine Besylate37$301
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst18$253
Losartan Potassium25$252
Methylprednisolone34$233
Levothyroxine Sodium40$212
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav22$211
Montelukast Sodium12$211
Fluticasone Propionate14$199
Metformin Hcl19$194

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanumet Xr$36$10,88416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 527 physician assistant providers in Delaware.

Other physician assistant in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →